Tranexamic Acid and Bevacizumab in Hereditary Hemorrhagic Telangiectasia Patients Presenting With Epistaxis

被引：0
|
作者：
Lacout, Alexis [1 ]
Marcy, Pierre-Yves [2 ]
El Hajjam, Mostafa [3 ]
Lacombe, Pascal [3 ]
机构：
[1] Ctr Imagerie Med, Aurillac, France
[2] Francois Baclesse Canc Res Inst, Radiodiagnost Dept, Caen, France
[3] Hop Ambroise Pare, AP HP, Serv Radiol, Boulogne Billancourt, France
来源：
CUTIS | 2013年 / 91卷 / 04期
关键词：
MUTATION; HHT;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [1] Bevacizumab injection for epistaxis in hereditary hemorrhagic telangiectasia
    Casady, Megan
    Burton, Claude
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB55 - AB55
  • [2] Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia
    Klepfish, A
    Berrebi, A
    Schattner, A
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (05) : 767 - 767
  • [3] Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis
    del Molino, AP
    Zarrabeitia, R
    Fernández, A
    Botella, LM
    MEDICINA CLINICA, 2004, 123 (03): : 118 - 119
  • [4] Is Bevacizumab Effective for Reducing Epistaxis in Hereditary Hemorrhagic Telangiectasia?
    Chin, Christopher J.
    LARYNGOSCOPE, 2017, 127 (02): : 289 - 290
  • [5] The Effect of Bevacizumab (Avastin) Treatment on Epistaxis in Hereditary Hemorrhagic Telangiectasia
    Simonds, Jana
    Miller, Frank
    Mandel, Jess
    Davidson, Terence M.
    LARYNGOSCOPE, 2009, 119 (05): : 988 - 992
  • [6] Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia
    Thompson, Andrew B.
    Ross, Douglas A.
    Berard, Paul
    Figueroa-Bodine, Jaszmin
    Livada, Nancy
    Richer, Sara L.
    ALLERGY & RHINOLOGY, 2014, 5 (02): : E91 - E95
  • [7] Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review
    Kini, Sameer D.
    Yiu, Daniel W.
    Weisberg, Reid A.
    Davila, Juan F.
    Chelius, Daniel C.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2019, 128 (05): : 467 - 471
  • [8] Tranexamic acid in hereditary hemorrhagic telangiectasia -: Reply
    Sabbá, C
    Gallitelli, M
    Ciavarella, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06): : 457 - 457
  • [9] CONTROL OF EPISTAXIS IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA
    SIEGEL, MB
    KEANE, WM
    ATKINS, JP
    ROSEN, MR
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1991, 105 (05) : 675 - 679
  • [10] Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Sabbà, C
    Gallitelli, M
    Palasciano, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12): : 926 - 926
12345